172 related articles for article (PubMed ID: 26575387)
1. Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis.
Migita K; Komori A; Kozuru H; Jiuchi Y; Nakamura M; Yasunami M; Furukawa H; Abiru S; Yamasaki K; Nagaoka S; Hashimoto S; Bekki S; Kamitsukasa H; Nakamura Y; Ohta H; Shimada M; Takahashi H; Mita E; Hijioka T; Yamashita H; Kouno H; Nakamuta M; Ario K; Muro T; Sakai H; Sugi K; Nishimura H; Yoshizawa K; Sato T; Naganuma A; Komatsu T; Oohara Y; Makita F; Tomizawa M; Yatsuhashi H
PLoS One; 2015; 10(11):e0136908. PubMed ID: 26575387
[TBL] [Abstract][Full Text] [Related]
2. Galectin-9 in autoimmune hepatitis: Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis.
Matsuoka N; Kozuru H; Koga T; Abiru S; Yamasaki K; Komori A; Fujita Y; Tenmoku J; Asano T; Sato S; Suzuki E; Furuya M; Kobayashi H; Watanabe H; Naganuma A; Yoshizawa K; Shimada M; Ario K; Yamashita H; Kohno H; Kaneyoshi T; Nakamura M; Furukawa H; Takahashi A; Kawakami A; Ohira H; Yatsuhashi H; Migita K
Medicine (Baltimore); 2019 Aug; 98(35):e16924. PubMed ID: 31464928
[TBL] [Abstract][Full Text] [Related]
3. Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis.
Saeki C; Matsuzaki J; Kuroda M; Fujita K; Ichikawa M; Takizawa S; Takano K; Oikawa T; Nakanuma Y; Saruta M; Ochiya T; Tsubota A
BMJ Open Gastroenterol; 2022 Apr; 9(1):. PubMed ID: 35379653
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.
Lee TH; Matta B; King BD; Hodges MR; Tillmann HL; Patel K
J Med Virol; 2015 Oct; 87(10):1722-6. PubMed ID: 25963774
[TBL] [Abstract][Full Text] [Related]
5. Autophagy, Mitophagy and MicroRNA Expression in Chronic Hepatitis C and Autoimmune Hepatitis.
Szekerczés T; Gógl A; Illyés I; Mandl J; Borka K; Kiss A; Schaff Z; Lendvai G; Werling K
Pathol Oncol Res; 2020 Oct; 26(4):2143-2151. PubMed ID: 32124227
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients.
El-Hefny M; Fouad S; Hussein T; Abdel-Hameed R; Effat H; Mohamed H; Abdel Wahab AH
J Med Virol; 2019 Jan; 91(1):93-101. PubMed ID: 30133717
[TBL] [Abstract][Full Text] [Related]
7. Serum cytokine profiles and Mac-2 binding protein glycosylation isomer (M2BPGi) level in patients with autoimmune hepatitis.
Migita K; Horai Y; Kozuru H; Koga T; Abiru S; Yamasaki K; Komori A; Fujita Y; Asano T; Sato S; Suzuki E; Matsuoka N; Kobayashi H; Watanabe H; Naganuma A; Naeshiro N; Yoshizawa K; Ohta H; Sakai H; Shimada M; Nishimura H; Tomizawa M; Ario K; Yamashita H; Kamitsukasa H; Kohno H; Nakamura M; Furukawa H; Takahashi A; Kawakami A; Ohira H; Yastuhashi H
Medicine (Baltimore); 2018 Dec; 97(50):e13450. PubMed ID: 30557999
[TBL] [Abstract][Full Text] [Related]
8. Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.
Trebicka J; Anadol E; Elfimova N; Strack I; Roggendorf M; Viazov S; Wedemeyer I; Drebber U; Rockstroh J; Sauerbruch T; Dienes HP; Odenthal M
J Hepatol; 2013 Feb; 58(2):234-9. PubMed ID: 23085648
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNA-196a as a candidate diagnostic biomarker for chronic hepatitis C.
Liu B; Xiang Y; Zhang HS
Mol Med Rep; 2015 Jul; 12(1):105-10. PubMed ID: 25738504
[TBL] [Abstract][Full Text] [Related]
10. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
Bihrer V; Friedrich-Rust M; Kronenberger B; Forestier N; Haupenthal J; Shi Y; Peveling-Oberhag J; Radeke HH; Sarrazin C; Herrmann E; Zeuzem S; Waidmann O; Piiper A
Am J Gastroenterol; 2011 Sep; 106(9):1663-9. PubMed ID: 21606975
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus.
Wang H; Peng W; Ouyang X; Li W; Dai Y
Transl Res; 2012 Sep; 160(3):198-206. PubMed ID: 22683424
[TBL] [Abstract][Full Text] [Related]
12. Effect of ursodeoxycholic acid on autoimmune-associated chronic hepatitis C.
Nakamura K; Yoneda M; Takamoto S; Nakade Y; Yokohama S; Tamori K; Aso K; Matui T; Sato Y; Aoshima M; Makino I
J Gastroenterol Hepatol; 1999 May; 14(5):413-8. PubMed ID: 10355503
[TBL] [Abstract][Full Text] [Related]
13. Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis.
Migita K; Nakamura M; Aiba Y; Kozuru H; Abiru S; Komori A; Fujita Y; Temmoku J; Asano T; Sato S; Furuya M; Naganuma A; Yoshizawa K; Shimada M; Ario K; Mannami T; Kohno H; Kaneyoshi T; Komura T; Ohira H; Yatsuhashi H
PLoS One; 2020; 15(12):e0238540. PubMed ID: 33347507
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNA profiles in patients with chronic hepatitis B, chronic hepatitis C, primary biliary cirrhosis, autoimmune hepatitis, nonalcoholic steatohepatitis, or drug-induced liver injury.
Yamaura Y; Tatsumi N; Takagi S; Tokumitsu S; Fukami T; Tajiri K; Minemura M; Yokoi T; Nakajima M
Clin Biochem; 2017 Dec; 50(18):1034-1039. PubMed ID: 28823616
[TBL] [Abstract][Full Text] [Related]
15. Correlation between circulating miR-122 and prognosis of chronic HBV-related liver failure.
Wang WJ; Lai RT; Lu J; Xiang XG; Zhao GD; Tang WL; Cai W; Wang H; Zhou HJ; Xie Q
J Dig Dis; 2016 May; 17(5):334-9. PubMed ID: 27059663
[TBL] [Abstract][Full Text] [Related]
16. Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients.
Butt AM; Raja AJ; Siddique S; Khan JS; Shahid M; Tayyab GU; Minhas Z; Umar M; Idrees M; Tong Y
Sci Rep; 2016 Feb; 6():21510. PubMed ID: 26898400
[TBL] [Abstract][Full Text] [Related]
17. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z
Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019
[TBL] [Abstract][Full Text] [Related]
18. Differences in serum microRNA profiles in hepatitis B and C virus infection.
Akamatsu S; Hayes CN; Tsuge M; Miki D; Akiyama R; Abe H; Ochi H; Hiraga N; Imamura M; Takahashi S; Aikata H; Kawaoka T; Kawakami Y; Ohishi W; Chayama K
J Infect; 2015 Mar; 70(3):273-87. PubMed ID: 25452043
[TBL] [Abstract][Full Text] [Related]
19. Relationship between serum adenosine deaminase levels and liver histology in autoimmune hepatitis.
Torgutalp M; Efe C; Babaoglu H; Kav T
World J Gastroenterol; 2017 Jun; 23(21):3876-3882. PubMed ID: 28638227
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
Xu J; Wu C; Che X; Wang L; Yu D; Zhang T; Huang L; Li H; Tan W; Wang C; Lin D
Mol Carcinog; 2011 Feb; 50(2):136-42. PubMed ID: 21229610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
